Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Psoriasis Patients Dissatisfied with Topical Therapy
NCT03000309Phase 4Completed
- Sponsor
- DermResearch
- Start
- Dec 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in plaque psoriasis, sponsored by DermResearch. Started Dec 2016; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03000309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000309.